Shahrokh Shariat

Shahrokh François Shariat (born September 20, 1973) has enjoyed a distinguished 25-year career in academic medicine and higher education. He is deeply committed to expanding access to education and science, fostering talent and innovative ideas that elevate individuals and communities through collaboration, shared goals, and visionary leadership.

Shahrokh Shariat
Born	(1973-09-20) September 20, 1973 (age 51) Tehran, Imperial State of Iran
Nationality	Austrian
Education	University of Vienna Baylor College of Medicine University of Texas Southwestern Medical Center Memorial Sloan-Kettering Cancer Center
Alma mater	University of Vienna Baylor College of Medicine University of Texas Southwestern Medical Center Memorial Sloan-Kettering Cancer Center
Occupation(s)	Physician, Surgeon, Oncologist, Urologist
Website	Official website Medical University of Vienna

Since 2013, Dr. Shariat has served as Professor and Chairman of the Department of Urology, as well as Acting Chair of the Comprehensive Cancer Center at the Medical University of Vienna and Vienna General Hospital.

He also holds adjunct professorships at Weill Cornell Medical Center, New York, University of Texas Southwestern Medical Center, Dallas, and the Faculty of Medicine at Charles University, Prague. Additionally, he is an Honorary Professor of Urology at the University of Jordan, Amman, and the University of Tabriz, Iran, and has been awarded honorary doctorates from Carol Davila University of Medicine and Pharmacy, Bucharest, and Semmelweis University, Budapest.

Biography and Research Focus

Dr. Shariat has published over 2,195 peer-reviewed research papers (Scopus h-index 134, 80,992 citations; Google Scholar h-index 158, 109,847 citations), more than 700 non-peer-reviewed articles, and over 30 book chapters. He holds four patents related to his groundbreaking research on prostate and bladder cancers and has been honored with numerous national and international awards, including the prestigious Matula Award from the European Urological Association in 2014 and the Gold Cystoscope Award from the American Urological Association in 2017.

In addition to his academic roles, Dr. Shariat is a leader in professional societies, serving as President of the Austrian Urological Society and the Central European Urological Society.

He spearheads several collaborative, multicenter research groups, such as the Bladder Cancer Research Consortium, the Bladder Cancer Detection Group, and the Upper Tract Urothelial Carcinoma Collaboration, as well as leading prospective clinical trials.

He is an active member of various academic societies, serves as a reviewer for numerous national and international journals and organizations, and sits on the editorial boards of multiple scientific publications. Dr. Shariat is also committed to humanitarian efforts, heading a medical charity for refugees and serving on the medical advisory boards of two additional charitable organizations.

His research focusses on molecular mechanisms, markers, early detection, natural history, treatment, and translational as well as outcomes research in urologic maladies.  His laboratory research focuses on integrative genomics and epi-genomics of genito-urinary carcinoma with the goal of designing personalized therapeutic strategies.  Through a well-designed translational, interdisciplinary network of collaborators, his team was able to progress compounds from cell-line-based drug screens through mechanistic and efficacy assessment in vitro and in vivo experiments to Phase I human clinical trials.  Under his leadership, the Department of Urology at the Medical University of Vienna reshaped the vision of what a Urologist should be from a largely surgical specialist to a patient-centered, research-driven, outcomes-oriented expert.